Global Bioprocess Validation Market 2024-2028
The bioprocess validation market is forecasted to grow by USD 364 mn during 2023-2028, accelerating at a CAGR of 12.88% during the forecast period. The report on the bioprocess validation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for biopharmaceuticals, increasing need for quality control in pharmaceutical and biotechnology industries, and rising demand for personalized medicine.
Technavio's bioprocess validation market is segmented as below:
By End-user
- Pharmaceutical companies
- Contract development and manufacturing organizations
- Others
By Type
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing adoption of single-use technologies as one of the prime reasons driving the bioprocess validation market growth during the next few years. Also, rising number of drug approvals and increasing investments in biopharmaceutical manufacturing facilities will lead to sizable demand in the market.
The report on the bioprocess validation market covers the following areas:
- Bioprocess validation market sizing
- Bioprocess validation market forecast
- Bioprocess validation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bioprocess validation market vendors that include Agilent Technologies Inc., Asahi Kasei Corp., Avantor Inc., Bangalore Biotech labs Pvt. Ltd., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, GEA Group AG, Hangzhou Cobetter Filtration Equipment Co. Ltd., Laboratory Corp. of America Holdings, Lonza Group Ltd., Meissner Filtration Products Inc., Merck KGaA, Porvair Plc, ProPharma Group Holdings LLC, Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and W. L. Gore and Associates Inc.. Also, the bioprocess validation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.